Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice
- PMID: 10426388
- DOI: 10.2337/diabetes.48.8.1662
Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice
Abstract
Although the precise mechanisms contributing to insulin resistance and type 2 diabetes are unknown, it is believed that defects in downstream components of the insulin signaling pathway may be involved. In this work, we hypothesize that a serine/threonine kinase, glycogen synthase kinase-3 (GSK-3), may be pertinent in this regard. To test this hypothesis, we examined GSK-3 activity in two inbred mouse strains known to be susceptible (C57BL/6J) or resistant (A/J) to diet-induced obesity and diabetes. Examination of GSK-3 in fat, liver, and muscle tissues of C57BL/6J mice revealed that GSK-3 activity increased twofold in the epididymal fat tissue and remained unchanged in muscle and liver of mice fed a high-fat diet, compared with their low-fat diet-fed counterparts. In contrast, GSK-3 activity did not change in the epididymal fat tissue of A/J mice, regardless of the type of diet they were fed. In addition, both basal and diet-induced GSK-3 activity was higher (2.3- and 3.2-fold, respectively) in the adipose tissue of C57BL/6J mice compared with that in A/J mice. Taken together, our studies suggest an unsuspected link between increased GSK-3 activity and development of insulin resistance and type 2 diabetes in fat tissue of C57BL/6J mice, and implicate GSK-3 as a potential factor contributing to susceptibility of C57BL/6J mice to diet-induced diabetes.
Similar articles
-
Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats.Diabetes. 2001 Mar;50(3):573-83. doi: 10.2337/diabetes.50.3.573. Diabetes. 2001. PMID: 11246877
-
The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.J Immunol. 1999 Aug 15;163(4):1894-905. J Immunol. 1999. PMID: 10438924
-
The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.J Immunol. 2002 Jul 15;169(2):758-69. doi: 10.4049/jimmunol.169.2.758. J Immunol. 2002. PMID: 12097378
-
Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart.Diabetes. 2001 Dec;50(12):2709-20. doi: 10.2337/diabetes.50.12.2709. Diabetes. 2001. PMID: 11723053
-
Glycogen synthase kinase 3: an emerging therapeutic target.Trends Mol Med. 2002 Mar;8(3):126-32. doi: 10.1016/s1471-4914(01)02266-3. Trends Mol Med. 2002. PMID: 11879773 Review.
Cited by
-
Gene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesity.Physiol Rev. 2015 Jan;95(1):47-82. doi: 10.1152/physrev.00007.2014. Physiol Rev. 2015. PMID: 25540138 Free PMC article. Review.
-
Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?Biochem Soc Trans. 2004 Nov;32(Pt 5):803-8. doi: 10.1042/BST0320803. Biochem Soc Trans. 2004. PMID: 15494020 Free PMC article. Review.
-
Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose Intolerance.Cells. 2022 Feb 5;11(3):559. doi: 10.3390/cells11030559. Cells. 2022. PMID: 35159367 Free PMC article.
-
Antidiabetic and vasoprotective activity of lithium: Role of glycogen synthase kinase-3.Indian J Pharmacol. 2011 Jul;43(4):433-6. doi: 10.4103/0253-7613.83116. Indian J Pharmacol. 2011. PMID: 21845000 Free PMC article.
-
Knockdown of GSK3β increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells.Biosci Rep. 2016 Sep 16;36(5):e00382. doi: 10.1042/BSR20160174. Print 2016 Oct. Biosci Rep. 2016. PMID: 27534430 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases